Huocong Huang

2.3k total citations · 1 hit paper
33 papers, 1.3k citations indexed

About

Huocong Huang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Huocong Huang has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Huocong Huang's work include Pancreatic and Hepatic Oncology Research (13 papers), Cell Adhesion Molecules Research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Huocong Huang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Cell Adhesion Molecules Research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Huocong Huang collaborates with scholars based in United States, United Kingdom and China. Huocong Huang's co-authors include Rolf A. Brekken, Wenting Du, Zhaoning Wang, Debolina Ganguly, Steven H. Wright, Yuqing Zhang, Noah Sorrelle, Gilbert Z. Murimwa, Sören Müller and Ravikanth Maddipati and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Immunology.

In The Last Decade

Huocong Huang

31 papers receiving 1.3k citations

Hit Papers

Mesothelial cell-derived ... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huocong Huang United States 18 803 493 464 254 152 33 1.3k
Kabir A. Khan United Kingdom 15 489 0.6× 547 1.1× 320 0.7× 217 0.9× 163 1.1× 21 1.2k
Jacqueline Lesperance United States 16 478 0.6× 819 1.7× 248 0.5× 205 0.8× 165 1.1× 25 1.2k
Evangeline Mose United States 18 551 0.7× 563 1.1× 283 0.6× 239 0.9× 49 0.3× 25 1.2k
Ruben Bill Switzerland 11 554 0.7× 557 1.1× 374 0.8× 333 1.3× 68 0.4× 20 1.2k
Molly A. Taylor United States 18 624 0.8× 970 2.0× 432 0.9× 510 2.0× 88 0.6× 30 1.7k
Marjo Hahka‐Kemppinen Finland 18 651 0.8× 545 1.1× 220 0.5× 198 0.8× 156 1.0× 33 1.1k
Gabriel J. Villares United States 18 330 0.4× 666 1.4× 241 0.5× 271 1.1× 124 0.8× 19 1.2k
Surabhi Dangi‐Garimella United States 14 673 0.8× 749 1.5× 200 0.4× 426 1.7× 100 0.7× 34 1.4k
Albert Santamaria‐Martínez Switzerland 13 865 1.1× 710 1.4× 198 0.4× 410 1.6× 89 0.6× 20 1.5k
Rolf Warta Germany 21 335 0.4× 532 1.1× 261 0.6× 324 1.3× 61 0.4× 53 1.2k

Countries citing papers authored by Huocong Huang

Since Specialization
Citations

This map shows the geographic impact of Huocong Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huocong Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huocong Huang more than expected).

Fields of papers citing papers by Huocong Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huocong Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huocong Huang. The network helps show where Huocong Huang may publish in the future.

Co-authorship network of co-authors of Huocong Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Huocong Huang. A scholar is included among the top collaborators of Huocong Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huocong Huang. Huocong Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murimwa, Gilbert Z., Dina Alzhanova, Jill M. Westcott, et al.. (2025). SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition. Cancer Research. 85(16). 2987–2996. 2 indexed citations
2.
Chen, Xiongfeng, Zhuan Zhou, Luyu Xie, et al.. (2025). Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches. Cancer Cell. 43(12). 2224–2240.e9.
3.
Zhang, Yichi, Matthieu Dos Santos, Huocong Huang, et al.. (2024). A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution. Cell Reports. 43(8). 114587–114587. 9 indexed citations
4.
Chen, Xiongfeng & Huocong Huang. (2024). Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts. Cancer Cell. 42(5). 744–746. 2 indexed citations
5.
Shah, Akansha M., Lei Guo, María Gabriela Morales, et al.. (2023). TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma. Science Advances. 9(17). eade8184–eade8184. 10 indexed citations
6.
Lou, Guohua, Xiao-Lu Teng, Haixia Wang, et al.. (2023). FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells. Nature Immunology. 25(1). 117–128. 29 indexed citations
7.
Huang, Huocong, Pravat Kumar Parida, Lan He, et al.. (2022). Cell Competition Shapes Metastatic Latency and Relapse. Cancer Discovery. 13(1). 85–97. 13 indexed citations
8.
9.
Du, Wenting, Huocong Huang, Zhaoning Wang, et al.. (2021). AXL Is a Key Factor for Cell Plasticity and Promotes Metastasis in Pancreatic Cancer. Molecular Cancer Research. 19(8). 1412–1421. 22 indexed citations
10.
Arner, Emily N., Ali A. Rizvi, Jason E. Toombs, et al.. (2021). AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer. Molecular Cancer Therapeutics. 21(1). 38–47. 22 indexed citations
11.
Huang, Huocong, et al.. (2021). VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment. JCI Insight. 6(23). 35 indexed citations
12.
Deng, Jenying, Ya’an Kang, Xinqun Li, et al.. (2021). DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI Insight. 6(17). 89 indexed citations
13.
Huang, Huocong & Rolf A. Brekken. (2020). Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer. American Journal of Physiology-Cell Physiology. 319(2). C233–C243. 36 indexed citations
14.
Zhu, Dongsheng, Huocong Huang, Daniel M. Pinkas, et al.. (2019). 2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy. Journal of Medicinal Chemistry. 62(16). 7431–7444. 54 indexed citations
15.
Huang, Huocong, Steven H. Wright, Junqiu Zhang, & Rolf A. Brekken. (2019). Getting a grip on adhesion: Cadherin switching and collagen signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(11). 118472–118472. 29 indexed citations
16.
Kirane, Amanda, Huocong Huang, Noah Sorrelle, et al.. (2018). Cyclooxygenase-2 Inhibition Potentiates the Efficacy of Vascular Endothelial Growth Factor Blockade and Promotes an Immune Stimulatory Microenvironment in Preclinical Models of Pancreatic Cancer. Molecular Cancer Research. 17(2). 348–355. 15 indexed citations
18.
Aguilera, Kristina Y., Huocong Huang, Wenting Du, et al.. (2017). Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics. 16(11). 2473–2485. 88 indexed citations
19.
Huang, Huocong, Robert A. Svoboda, Audrey J. Lazenby, et al.. (2016). Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1. Journal of Biological Chemistry. 291(44). 23208–23223. 52 indexed citations
20.
Li, Zhixue, Daming Deng, Huocong Huang, et al.. (2012). Overexpression of Six1 leads to retardation of myogenic differentiation in C2C12 myoblasts. Molecular Biology Reports. 40(1). 217–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026